<?xml version="1.0" encoding="UTF-8"?>
<ref id="B18-antioxidants-09-00573">
 <label>18.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Sharma</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Rizky</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Stefanovic</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Tate</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Ritchie</surname>
    <given-names>R.H.</given-names>
   </name>
   <name>
    <surname>Ward</surname>
    <given-names>K.W.</given-names>
   </name>
   <name>
    <surname>de Haan</surname>
    <given-names>J.B.</given-names>
   </name>
  </person-group>
  <article-title>The nuclear factor (erythroid-derived 2)-like 2 (Nrf2) activator dh404 protects against diabetes-induced endothelial dysfunction</article-title>
  <source>Cardiovasc. Diabetol.</source>
  <year>2017</year>
  <volume>16</volume>
  <fpage>33</fpage>
  <pub-id pub-id-type="doi">10.1186/s12933-017-0513-y</pub-id>
  <pub-id pub-id-type="pmid">28253885</pub-id>
 </element-citation>
</ref>
